Rectal cancer

11 trials 6 recruiting MedDRA PT
11 Registered trials
6 Recruiting
10 Unique sponsors
10 Unique IMPs
1 Commercial trials
Drug classes (ATC)
— ATC code not specified 5
L Oncology (ATC L) 5
V Various (ATC V) 4
N Neurology/Psychiatry (ATC N) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 4 substances
Antimetabolite 2 substances
Supportive / rescue 1 substance
Topoisomerase I inhibitor 1 substance
Platinum compound 1 substance
Monoclonal antibody (immune) 1 substance
Phase III: 4 Phase II: 6 Phase I: 1

Filter these 11 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 11 trials

Phase III

4 trials
  • Catharina Ziekenhuis Stichting Academic
    FLUOROURACIL; FOLINIC ACID; IRINOTECAN HYDROCHLORIDE TRIHYDRATE; OXALIPLATIN
    2025-523692-39-00 1 country 2026 n=394
    Recruiting
  • Centre Hospitalier Universitaire De Bordeaux Academic
    CAPECITABINE; FLUOROURACIL; IRINOTECAN HYDROCHLORIDE TRIHYDRATE; LEVOLEUCOVORIN; OXALIPLATIN
    2024-514705-62-00 1 country 2019 n=186
    Ended
  • Goethe University Frankfurt Academic
    CALCIUM FOLINATE PENTAHYDRATE; CAPECITABINE; FLUOROURACIL; OXALIPLATIN
    2024-511577-29-01 1 country 2020 n=688
    Ended
  • Varsinais-Suomen hyvinvointialue Academic
    IMP not specified
    2024-514831-34-00 1 country 2024 n=60
    Recruiting

Phase II

6 trials
  • NanoEcho AB (publ) Commercial
    FERUMOXTRAN-10
    2024-515335-29-00 1 country 2024 n=45
    Recruiting
  • Catharina Ziekenhuis Stichting Academic
    FLUOROURACIL; FOLINIC ACID; IRINOTECAN HYDROCHLORIDE TRIHYDRATE; OXALIPLATIN
    2023-509758-74-00 1 country 2021 n=128
    Ended
  • Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia Academic
    IMIPRAMINE HYDROCHLORIDE
    2023-504943-15-00 1 country 2022 n=180
    Recruiting
  • G.O.I.R.C. Gruppo Oncologico Italiano Di Ricerca Clinica Academic
    DOSTARLIMAB
    2024-519798-20-00 1 country 2026 n=270
    Recruiting
  • Grupo Espanol Multidisciplinar En Cancer Digestivo Academic
    IMP not specified
    2024-515240-24-00 1 country n=60
    Pending
  • IRCCS Istituto Nazionale Tumori Fondazione Pascale Academic
    IMP not specified
    2024-519050-37-00 1 country n=70
    Pending

Phase I

1 trial
  • Universitair Medisch Centrum Groningen Academic
    IMP not specified
    2023-507106-13-00 1 country 2026 n=23
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Catharina Ziekenhuis Stichting Academic 2 Phase II, Phase III 1
NanoEcho AB (publ) Commercial 1 Phase II 1
Universitair Medisch Centrum Groningen Academic 1 Phase I 1
Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia Academic 1 Phase II 1
G.O.I.R.C. Gruppo Oncologico Italiano Di Ricerca Clinica Academic 1 Phase II 1
Grupo Espanol Multidisciplinar En Cancer Digestivo Academic 1 Phase II 0
IRCCS Istituto Nazionale Tumori Fondazione Pascale Academic 1 Phase II 0
Centre Hospitalier Universitaire De Bordeaux Academic 1 Phase III 0
Goethe University Frankfurt Academic 1 Phase III 0
Varsinais-Suomen hyvinvointialue Academic 1 Phase III 1
New trials by year
2019
1
2020
1
2021
1
2022
1
2024
2
2026
3
← All indication landscapes